The corticotropin-releasing factor system as a potential target for antiobesity drugs

Drug News and Perspectives

Volumn 17, Issue 8, 2004, Pages 505-517

  Doyon, Christian ^a   Moraru, Arthur ^a   Richard, Denis ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2; UROCORTIN III;

ANOREXIA; ANXIETY DISORDER; BEHAVIOR; CARDIOVASCULAR FUNCTION; COLON MOTILITY; DRUG ACTIVITY; DRUG TARGETING; ENERGY BALANCE; ENERGY METABOLISM; GASTROINTESTINAL TRACT FUNCTION; HYPOPHYSIS ADRENAL SYSTEM; OBESITY; PHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; THERMOGENESIS;

EID: 10444240969     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2004.17.8.863694     Document Type: Review

References (171)

1. Richard, D., Lin, Q. and Timofeeva, E. The corticotropin-releasing factor family of peptides and CRF receptors: Their roles in the regulation of energy balance. Eur J Pharmacol 2002, 440: 189-97.
2. Vale, W., Spiess, J., Rivier, C. and Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213: 1394-7.
3. Vaughan, J., Donaldson, C., Bittencourt, J. et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378: 287-92.
4. Hsu, S.Y. and Hsueh, A.J. Hitman stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 2001, 7: 605-11.
5. Reyes, T.M., Lewis, K., Perrin, M.H. et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001, 98: 2843-8.
6. Lewis, K., Li, C., Perrin, M.H. et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001, 98: 7570-5.
7. Lederis, K., Letter, A., McMaster, D., Moore, G. and Schlesinger, D. Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science 1982, 218: 162-5.
8. Ichikawa, T., McMaster, D., Lederis, K. and Kobayashi, H. Isolation and amino acid sequence of urotensin I, a vasoactive and ACTH-releasing neuropeptide, from the carp (Cyprinus carpio) urophysis. Peptides 1982, 3: 859-67.
9. Montecucchi, P.C., Anastasi, A., de Castiglione, R. and Erspamer, V. Isolation and amino acid composition of sauvagine. An active polypeptide from methanol extracts of the skin of the South American frog Phyllomedusa sauvagei. Int J Pept Protein Res 1980, 16: 191-9.
10. Chang, C.P., Pearse, R.V., 2nd, O'Connell, S. and Rosenfeld, M.G. Identification of a seven transmembrane helix, receptor for corticotropin- releasing factor and sauvagine in mammalian brain. Neuron 1993, 11: 1187-95.
11. Perrin, M.H., Donaldson, C.J., Chen, R., Lewis, K.A. and Vale, W.W. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 1993, 133: 3058-61.
12. Vita, N., Laurent, P., Lefort, S. et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 1993, 335: 1-5.
13. Chen, R., Lewis, K.A., Perrin, M.H. and Vale, W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993, 90: 8967-71.
14. Lovenberg, T.W., Liaw, C.W., Grigoriadis, D.E. et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 1995, 92: 836-40.
15. Kishimoto, T., Pearse, R.V, 2nd, Lin, C.R. and Rosenfeld, M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 1995, 92: 1108-12.
16. Perrin, M., Donaldson, C., Chen, R. et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 1995, 92: 2969-73.
17. Stenzel, P., Kesterson, R., Yeung, W., Cone, R.D., Rittenberg, M.B. and Stenzel-Poore, M.P. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 1995, 9: 637-45.
18. Arai, M., Assil, I.Q. and Abou-Samra, A.B. Characterization of three corticotropin-releasing factor receptors in catfish: A novel third receptor is predominantly expressed in pituitary and urophysis. Endocrinology 2001, 142: 446-54.
19. Spiess, J., Rivier, J., Rivier, C. and Vale, W. Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci USA 1981, 78: 6517-21.
20. Reul, J.M. and Holsboer, F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002, 2: 23-33.
21. Merchenthaler, I., Vigh, S., Petrusz, P. and Schally, A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 1982, 165: 385-96.
22. Turnbull, A.V. and Rivier, C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 1997, 215: 1-10.
23. Fisher, L.A. and Brown, M.R. Central regulation of stress responses: Regulation of the autonomic nervous system and visceral function by corticotrophin releasing factor-41. Baillieres Clin Endocrinol Metab 1991, 5: 35-50.
24. Heinrichs, S.C. and Taché, Y. Therapeutic potential of CRF receptor antagonists: A gut-brain perspective. Expert Opin Investig Drugs 2001, 10: 647-59.
25. Dunn, A.J. and Berridge, C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990, 15: 71-100.
26. Krysiak, R., Obuchowicz, E. and Herman, Z.S. Role of corticotropin- releasing factor (CRF) in anxiety. Pol J Pharmacol 2000, 52: 15-25.
27. Fisher, L.A., Rivier, J., Rivier, C., Spiess, J., Vale, W. and Brown, M.R. Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982, 110: 2222-4.
28. LeFeuvre, R.A., Rothwell, N.J. and Stock, M.J. Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat. Neuropharmacology 1987, 26: 1217-21.
29. Arase, K., York, D.A., Shimizu, H., Shargill, N. and Bray, O.A. Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 1988, 255: E255-9.
30. Taché, Y., Gunion, M.M. and Stephens, R. CRF: Central nervous system action to influence gastrointestinal function and role in the gastrointestinal response to stress. In: Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. E.B. De Souza and C.B. Nemeroff (Eds.). CRC, Boca Raton 1990, 299-307.
31. Rivest, S. and Rivier, C. The role of corticotropin-releasing factor and interleukin-I in the regulation of neurons controlling reproductive functions. Endocr Rev 1995, 16: 177-99.
32. Heinrichs, S.C. and Richard, D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 1999, 33: 350-9.
33. Morin, S.M., Ling, N., Liu, X.J., Kahl, S.D. and Gehlert, D.R. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999, 92: 281-91.
34. Bittencourt, J.C., Vaughan, J., Arias, C., Rissman, R.A., Vale, W.W. and Sawchenko, P.E. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 1999, 415: 285-312.
35. Van Pett, K., Viau, V., Bittencourt, J.C. et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000, 428: 191-212.
36. Tanaka, Y., Makino, S., Noguchi, T., Tamura, K., Kaneda, T. and Hashimoto, K. Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat. Neuroendocrinology 2003, 78: 1-11.
37. Li, C., Vaughan, J., Sawchenko, P.E. and Vale, W.W. Urocortin III-immunoreactive projections in rat brain: Partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. J Neurosci 2002, 22: 991-1001.
38. Smith, G.W., Aubry, J.M., Dellu, F. et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuro endocrine development. Neuron 1998, 20: 1093-102.
39. Moreau, J.L., Kilpatrick, G. and Jenck, F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 1997, 8: 1697-701.
40. Inoue, K., Valdez, G.R., Reyes, T.M. et al. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the Rat. J Pharmacol Exp Ther 2003, 305: 385-93.
41. Zorrilla, E.P., Valdez, G.R., Inoue, K. et al. Central administration of urocortin 3, a type 2 corticotropin-releasing factor receptor agonist, suppresses food intake without malaise in the rat. Soc Neurosci Abstr 2003, 29: 928.7.
42. Mackay, K.B., Stiefel, T.H., Ling, N. and Foster, A.C. Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat. Eur J Pharmacol 2003, 469: 111-5.
43. Chen, C.Y., Doong, M.L., Rivier, J.E. and Taché, Y. Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats. Regul Pept 2003, 113: 125-30.
44. Martínez, V., Wang, L., Rivier, J.E., Vale, W. and Taché, Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: Role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 2002, 301: 611-7.
45. Million, M., Maillot, C., Saunders, P., Rivier, J., Vale, W. and Taché, Y. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Am J Physiol Gastrointest Liver Physiol 2002, 282: G34-40.
46. Valdez, G.R., Inoue, K., Koob, G.F., Rivier, J., Vale, W. and Zorrilla, E.P. Human urocortin II: Mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res 2002, 943: 142-50.
47. Valdez, G.R., Zorrilla, E.P., Rivier, J., Vale, W.W. and Koob, G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res 2003, 980: 206-12.
48. Pelleymounter, M.A., Joppa, M., Ling, N. and Foster, A.C. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J Pharmacol Exp Ther 2002, 302: 145-52.
49. Lovejoy, D.A. and Balment, R.J. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates. Gen Comp Endocrinol 1999, 115: 1-22.
50. Wong, M.L., Licinio, J., Pasternak, K.I. and Gold, P.W. Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry. Endocrinology 1994, 135: 2275-8.
51. Potter, E., Sutton, S., Donaldson, C. et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994, 91: 8777-81.
52. Dieterich, K.D., Lehnen, H. and De Souza, E.B. Corticotropin-releasing factor receptors: An overview. Exp Clin Endocrinol Diabetes 1997, 105: 65-82.
53. Timofeeva, E. and Richard, D. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinology 1997, 66: 327-40.
54. Bonaz, B. and Rivest, S. Effect of a chronic stress on CRF neuronal activity and expression of its type 1 receptor in the rat brain. Am J Physiol 1998, 275: R1438-49.
55. Richard, D., Rivest, R., Naimi, N., Timofeeva, E. and Rivest, S. Expression of corticotropin-releasing factor and its receptors in the brain of lean and obese Zucker rats. Endocrinology 1996, 137: 4786-95.
56. Rivest, S., Laflamme, N. and Nappi, R.E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci 1995, 15: 2680-95.
57. Timpl, P., Spanagel, R., Sillaber, I. et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998, 19: 162-6.
58. Preil, J., Müller, M.B., Gesing, A. et al. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 2001, 142: 4946-55.
59. Bale, T.L., Picetti, R., Contarino, A., Koob, G.F., Vale, W.W. and Lee, K.F. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 2002, 22: 193-9.
60. Bornstein, S.R., Webster, E.L., Torpy, D.J. et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology 1998, 139: 1546-55.
61. Pelleymounter, M.A., Joppa, M., Carmouche, M. et al. Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther 2000, 293: 799-806.
62. Ohata, H., Arai, K. and Shibasaki, T. Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress. Eur J Pharmacol 2002, 457: 201-6.
63. McElroy, J.F., Ward, K.A., Zeller, K.L. et al. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats. Psychopharmacology 2002, 165: 86-92.
64. Gutman, D.A., Owens, M.J., Skelton, K.H., Thrivikraman, K.V. and Nemeroff, C.B. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther 2003, 304: 874-80.
65. Rivier, C.L., Grigoriadis, D.E. and Rivier, J.E. Role of corticotropin-releasing factor receptors Type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology 2003, 144: 2396-403.
66. Hope, P.J., Turnbull, H., Farr, S. et al. Peripheral administration of CRF and urocortin: Effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata. Peptides 2000, 21: 669-77.
67. Gully, D., Geslin, M., Serva, L. et al. 4-(2-Chloro-4-methoxy-5- methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl] 5-methyl-N-(2-propynyl)-1,3-thiaiol-2-amine hydrochloride (SSRI25543A): A potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization. J Pharmacol Exp Ther 2002, 301: 322-32.
68. Habib, K.E., Weld, K.P., Rice, K.C. et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000, 97: 6079-84.
69. Contarino, A., Dellu, F., Koob, G.F. et al. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res 1999, 835: 1-9.
70. Müller, M.B., Zimmermann, S., Sillaber, I. et al. Limbic corticotropin-releasing hormone receptor I mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 2003, 6: 1100-7.
71. Liebsch, G., Landgraf, R., Gerstberger, R. et al. Chronic infusion of a CRHI receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 1995, 59: 229-39.
72. Liebsch, G., Landgraf, R., Engelmann, M., Lorscher, P. and Holsboer, F. Differential behavioral effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J Psychiatr Res 1999, 33: 153-63.
73. Heinrichs, S.C., Lapsansky, J., Lovenberg, T.W., De Souza, E.B. and Chalmers, D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Pept 1997, 71: 15-21.
74. Skutella, T., Probst, J.C., Renner, U., Holsboer, F. and Behl, C. Corticotropin-releasing hormone receptor (type I) anti-sense targeting reduces anxiety. Neuroscience 1998, 85: 795-805.
75. Arborelius, L., Skelton, K.H., Thrivikraman, K.V., Plotsky, P.M., Schulz, D.W. and Owens, M.J. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat. J Pharmacol Exp Ther 2000, 294: 588-97.
76. Schulz, D.W., Mansbach, R.S., Sprouse, J. et al. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 1996, 93: 10477-82.
77. Zorrilla, E.P., Valdez, G.R., Nozulak, J., Koob, G.F. and Markou, A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res 2002, 952: 188-99.
78. Deak, T., Nguyen, K.T., Ehrlich, A.L. et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 1999, 140: 79-86.
79. Griebel, G., Simiand, J., Steinberg, R. et al. 4-(2-Chloro-4-methoxy-5- methylphenyl)-N-[(IS)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl] 5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSRI25543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models: of stress-related disorders. J Pharmacol Exp Ther 2002, 301: 333-45.
80. Basso, A.M., Spina, M., Rivier, J., Vale, W. and Koob, G.F. Corticotropin-releasing factor antagonist attenuates the "anxiogenic- like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 1999, 145: 21-30.
81. Okuyama, S., Chaki, S., Kawashima, N. et al. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin- releasing factor subtype I receptor antagonists CRAI000 and CRAI001. J Pharmacol Exp Ther 1999, 289: 926-35.
82. Ho, S.P., Takahashi, L.K., Livanov, V. et al. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Brain Res Mol Brain Res 2001, 89: 29-40.
83. Bakshi, V.P., Smith-Roe, S., Newman, S.M., Grigoriadis, D.E. and Kalin, N.H. Reduction of stress-induced behavior by antagonism of corticotropin- releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J Neurosci 2002, 22: 2926-35.
84. Risbrough, V.B., Hauger, R.L., Pelleymounter, M.A. and Geyer, M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology 2003, 170: 178-87.
85. Taché, Y., Martínez, V., Million, M. and Wang, L. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: Role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001, 280: G173-7.
86. Million, M., Grigoriadis, D.E., Sullivan, S. et al. A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats. Brain Res 2003, 985: 32-42.
87. Martínez, V. and Taché, Y. Role of CRF receptor I in central CRF-induced stimulation of colonic propulsion in rats. Brain Res 2001, 893: 29-35.
88. Martínez, V., Rivier, J., Wang, L. and Taché, Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther 1997, 280: 754-60.
89. Wang, L., Martínez, V., Vale, W. and Taché, Y. Fos induction in selective hypothalamic neuroendocrine and medullary nuclei by intravenous injection of urocortin and corticotropin-releasing factor in rats. Brain Res 2000, 855: 47-57.
90. Maillot, C., Wang, L., Million, M. and Taché, Y. Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats. Brain Res 2003, 974: 70-81.
91. Saunders, P.R., Maillot, C., Million, M. and Taché, Y. Peripheral corticotropin-releasing factor induces diarrhea in rats: Role of CRF1 receptor in fecal watery excretion. Eur J Pharmacol 2002, 435: 231-5.
92. Kostich, W.A., Chen, A., Sperle, K. and Largent, B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: The CRF2gamma receptor. Mol Endocrinol 1998, 12: 1077-85.
93. Lovenberg, T.W., Chalmers, D.T., Liu, C. and De Souza, E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995, 136: 4139-42.
94. Chalmers, D.T., Lovenberg, T.W., Grigoriadis, D.E., Behan, O.P. and De Souza, E.B. Corticotrophin-releasing factor receptors: From molecular biology to drug design. Trends Pharmacol Sci 1996, 17: 166-72.
95. Kageyama, K., Li, C. and Vale, W.W. Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: Localization and regulation by immune challenge, restraint stress, and glucocorticoids. Endocrinology 2003, 144: 1524-32.
96. Bale, T.L., Contarino, A., Smith, G.W. et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress. Nat Genet 2000, 24: 410-4.
97. Coste, S.C., Kesterson, R.A., Heldwein, K.A. et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000, 24: 403-9.
98. Smagin, G.N., Howell, L.A., Ryan, D.H., De Souza, E.B. and Harris, R.B. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia. Neuroreport 1998, 9: 1601-6.
99. Hashimoto, K., Makino, S., Asaba, K. and Nishiyama, M. Physiological roles of corticotropin-releasing hormone receptor type 2. Endocr J 2001, 48: 1-9.
100. Takahashi, L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci Biobehav Rev 2001, 25: 627-36.
101. Kishimoto, T., Radulovic, J., Radulovic, M. et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000, 24: 415-9.
102. Takahashi, L.K., Ho, S.P., Livanov, V., Graciani, N. and Arneric, S.P. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res 2001, 902: 135-42.
103. Ruhmann, A., Bonk, I., Lin, C.R., Rosenfeld, M.G. and Spiess, J. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci USA 1998, 95: 15264-9.
104. Radulovic, J., Ruhmann, A., Liepold, T. and Spiess, J. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2. J Neurosci 1999, 19: 5016-25.
105. Chalmers, D.T., Lovenberg, T.W. and De Souza, E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 1995, 15: 6340-50.
106. Parkes, D.G., Weisinger, R.S. and May, C.N. Cardiovascular actions of CRH and urocortin: An update. Peptides 2001, 22: 821-7.
107. Briscoe, R.J., Cabrera, C.L., Baird, T.J., Rice, K.C. and Woods, J.H. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Res 2000, 881: 204-7.
108. Brar, B.K., Jonassen, A.K., Egorina, E.M. et al. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 2004, 145: 24-35.
109. Asakawa, A., Inui, A., Ueno, N., Makino, S., Fujino, M.A. and Kasuga, M. Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 1999, 116: 1287-92.
110. Nozu, T., Martínez, V., Rivier, J. and Taché, Y. Peripheral urocortin delays gastric emptying: Role of CRF receptor 2. Am J Physiol 1999, 276: G867-74.
111. Wang, L., Martínez, V., Rivier, J.E. and Taché, Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: Differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 2001, 281: R1401-10.
112. Chen, C.Y., Million, M., Adelson, D.W., Martínez, V., Rivier, J. and Taché, Y. Intra-cisternal urocortin inhibits vagally stimulated gastric motility in rats: Role of CRF(2). Br J Pharmacol 2002, 136: 237-47.
113. Martínez, V., Barquist, E., Rivier, J. and Taché, Y. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: The role of CRF2 receptors. Am J Physiol 1998, 274: G965-70.
114. Orth, D.N. and Mount, C.D. Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun 1987, 143: 411-7.
115. Behan, D.P., Linton, E.A. and Lowry, P.J. Isolation of the human plasma corticotrophin-releasing factor-binding protein. J Endocrinol 1989, 122: 23-31.
116. Kemp, C.F., Woods, R.J. and Lowry, P.J. The corticotrophin-releasing factor-binding protein: An act of several parts. Peptides 1998, 19: 1119-28.
117. Baigent, S.M. and Lowry, P.J. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol 2000, 25: 43-52.
118. Potter, E., Behan, O.P., Fischer, W.H., Linton, E.A., Lowry, P.J. and Vale, W.W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 1991, 349: 423-6.
119. Potter, E., Behan, O.P., Linton, E.A., Lowry, P.J., Sawchenko, P.E. and Vale, W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 1992, 89: 4192-6.
120. Sutton, S.W., Behan, D.P., Lahrichi, S.L. et al. Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology 1995, 136: 1097-102.
121. Seasholtz, A.F., Valverde, R.A. and Denver, R.J. Corticotropin-releasing hormone-binding protein: Biochemistry and function from fishes to mammals. J Endocrinol 2002, 175: 89-97.
122. McLean, M., Bisits, A., Davies, J., Woods, R., Lowry, P. and Smith, R. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1: 460-3.
123. Zhao, X.J., Hoheisel, G., Schauer, J. and Bornstein, S.R. Corticotropin-releasing hormone-binding protein and its possible role in neuroendocrinological research. Horm Metab Res 1997, 29: 373-8.
124. Petraglia, F., Potter, E., Cameron, V.A. et al. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 1993, 77: 919-24.
125. Burrows, H.L., Nakajima, M., Lesh, J.S. et al. Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. J Clin Invest 1998, 101: 1439-47.
126. Lovejoy, D.A., Aubry, J.M., Turnbull, A. et al. Ectopic expression of the CRF-binding protein: Minor impact on HPA axis regulation but induction of sexually dimorphic weight gain. J Neuroendocrinol 1998, 10: 483-91.
127. Karolyi, I.J., Burrows, H.L., Ramesh, T.M. et al. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci USA 1999, 96: 11595-600.
128. McClennen, S.J., Cortright, D.N. and Seasholtz, A.F. Regulation of pituitary corticotropin-releasing hormone-binding protein messenger ribonucleic acid levels by restraint stress and adrenalectomy. Endocrinology 1998, 139: 4435-41.
129. Chan, R.K., Vale, W.W. and Sawchenko, P.E. Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain. Neuroscience 2000, 101: 115-29.
130. Behan, D.P., Heinrichs, S.C., Troncoso, J.C. et al. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 1995, 378: 284-7.
131. Rothwell, N.J. Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev 1990, 14: 263-71.
132. Benoit, S.C., Thiele, T.E., Heinrichs, S.C., Rushing, P.A., Blake, K.A. and Steeley, R.J. Comparison of central administration of corticotropin- releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression. Peptides 2000, 21: 345-51.
133. Wang, C., Mullet, M.A., Glass, M.J., Billington, C.J., Levine, A.S. and Kotz, C.M. Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 2001, 280: R473-80.
134. Wang, C. and Kotz, C.M. Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus. Am J Physiol Regul Integr Comp Physiol 2002, 283: R358-67.
135. Krahn, D.D., Gosnell, B.A., Levine, A.S. and Morley, J.E. Behavioral effects of corticotropin-releasing factor: Localization and characterization of central effects. Brain Res 1988, 443: 63-9.
136. Rivest, S. and Richard, D. Involvement of corticotropin-releasing factor in the anorexia induced by exercise. Brain Res Bull 1990, 25: 169-72.
137. Shibasaki, T., Yamauchi, N., Kato, Y. et al. Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat. Life Sci 1988, 43: 1103-10.
138. Dagnault, A., Ouerghi, D. and Richard, D. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of I7-beta-estradiol. Brain Res Bull 1993, 32: 689-92.
139. Racotta, I.S., Leblanc, J. and Richard, D. The effect of caffeine on food intake in rats: Involvement of corticotropin-releasing factor and the sympatho-adrenal system. Pharmacol Biochem Behav 1994, 48: 887-92.
140. Spina, M., Merlo-Pich, E., Chan, R.K. et al. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996, 273: 1561-4.
141. Shade, R.E., Blair-West, J.R., Carey, K.D. et al. Ingestive responses to administration of stress hormones in baboons. Am J Physiol Regul Integr Comp Physiol 2002, 282: R10-8.
142. Ohata, H., Suzuki, K., Oki, Y. and Shibasaki, T. Urocortin in the ventromedial hypothalamic nucleus acts as an inhibitor of feeding behavior in rats. Brain Res 2000, 861: 1-7.
143. Currie, P.J., Coscina, D.V., Bishop, C. et al. Hypothalamic paraventricular nucleus injections of urocortin alter food intake and respiratory quotient. Brain Res 2001, 916: 222-8.
144. Kelly, A.B. and Watts, A.G. The region of the pontine parabrachial nucleus is a major target of dehydration-sensitive CRH neurons in the rat lateral hypothalamic area. J Comp Neurol 1998, 394: 48-63.
145. Watts, A.C., Sanchez-Watts, G. and Kelly, A.B. Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia. J Neurosci 1999, 19: 6111-21.
146. Lin, Q., Huang, Q., Picard, F., Deshaies, Y. and Richard, D. Urocortin mRNA levels in the Edinger-Westphal nucleus is down-regulated in several rodent models of obesity and by urocortin. Soc Neurosci Abstr 2001, 27: 636.1.
147. Egawa, M., Yoshimatsu, H. and Bray, G.A. Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity. Am J Physiol 1990, 259: R799-806.
148. Rohner-Jeanrenaud, F., Walker, C.D., Greco-Perotto, R. and Jeanrenaud, B. Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 1989, 124: 733-9.
149. Heinrichs, S.C., Lapsansky, J., Behan, D.P. et al. Corticotropin- releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 1996, 93: 15475-80.
150. Guillaume-Gentil, C., Rohner-Jeanrenaud, F., Abramo, F., Bestetti, G.E., Rossi, G.L. and Jeanrenaud, B. Abnormal regulation of the hypothalamo-pituitary- adrenal axis in the genetically obese fa/fa rat. Endocrinology 1990, 126: 1873-9.
151. Timofeeva, E. and Richard, D. Activation of the central nervous system in obese Zucker rats during food deprivation. J Comp Neurol 2001, 441: 71-89.
152. Feldkircher, K.M., Mistry, A.M. and Romsos, D.R. Adrenalectomy reverses pre-existing obesity in adult genetically obese (ob/ob) mice. Int J Obes Relat Metab Disord 1996, 20: 232-5.
153. Yukimura, Y. and Bray, G.A. Effects of adrenalectomy on body weight and the size and number of fat cells in the Zucker (fatty) rat. Endocr Res Commun 1978, 5: 189-98.
154. Yukimura, Y., Bray, G.A. and Wolfsen, A.R. Some effects of adrenalectomy in the fatty rat. Endocrinology 1978, 103: 1924-8.
155. Marchington, D., Rothwell, N.J., Stock, M.J. and York, D.A. Energy balance, diet-induced thermogenesis and brown adipose tissue in lean and obese (fa/fa) Zucker rats after adrenalectomy. J Nutr 1983, 113: 1395-402.
156. Heinrichs, S.C., Li, D.L. and Iyengar, S. Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Res 2001, 900: 177-85.
157. Contarino, A., Dellu, F., Koob, G.F. et al. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFRI-deficient mice. Endocrinology 2000, 141: 2698-702.
158. Bradbury, M.J., McBurnie, M.I., Denton, D.A., Lee, K.F. and Vale, W.W. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor I deficiency in mice. Endocrinology 2000, 141: 2715-24.
159. Hotta, M., Shibasaki, T., Arai, K. and Demura, H. Corticotropin-releasing factor receptor type I mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res 1999, 823: 221-5.
160. De Fanti, B.A. and Martínez, J.A. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 2002, 930: 37-41.
161. Cullen, M.J., Ling, N., Foster, A.C. and Pelleymounter, M.A. Urocortin, corticotropin releasing factor-2 receptors and energy balance. Endocrinology 2001, 142: 992-9.
162. Trayhurn, P. Brown adipose tissue: From thermal physiology to bioenergetics. J Biosci 1993, 18: 161-73.
163. Leblanc, J. and Villemaire, A. Throxine and noradrenaline on noradrenaline sensitivity, cold resistance, and brown fat. Am J Physiol 1970, 218: 1742-5.
164. Castonguay, T.W., Dallman, M.F. and Stern, J.S. Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. Am J Physiol 1986, 251: R923-33.
165. Cabanac, M. and Richard, D. The nature of the ponderostat: Hervey's hypothesis revived. Appetite 1996, 26: 45-54.
166. Strack, A.M., Bradbury, M.J. and Dallman, M.F. Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue. Am J Physiol 1995, 268: R183-91.
167. Arvaniti, K., Ricquier, D., Champigny, O. and Richard, D. Leptin and corticosterone have opposite effects on food intake and the expression of UCP1 mRNA in brown adipose tissue of lep(ob)/lep(ob) mice. Endocrinology 1998, 139: 4000-3.
168. Galpin, K.S., Henderson, R.G., James, W.P. and Trayhurn, P. GDP binding to brown-adipose-tissue mitochondria of mice treated chronically with corticosterone. Biochem J 1983, 214: 265-8.
169. Zorrilla, E.P., Taché, Y. and Koob, G.F. Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci 2003, 24: 421-7.
170. Makino, S., Nishiyama, M., Asaba, K., Gold, P.W. and Hashimoto, K. Altered expression of type 2 CRH receptor mRNA in the VMH by glucocorticoids and starvation. Am J Physiol 1998, 275: R1138-45.
171. Nishiyama, M., Makino, S., Asaba, K. and Hashimoto, K. Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat. J Neuroendocrinol 1999, 11: 307-14.